Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization

Clinical and Vaccine Immunology

Volumn 22, Issue 2, 2015, Pages 229-234

  Song, Joon Young ^a,j   Lee, Jin Soo ^b   Wie, Seong Heon ^c   Kim, Hyo Youl ^d   Lee, Jacob ^e   Seo, Yu Bin ^e   Jeong, Hye Won ^f   Kim, Shin Woo ^g   Lee, Sun Hee ^h   Park, Kyung Hwa ⁱ   Noh, Ji Yun ^a,j   Choi, Won Suk ^a   Cheong, Hee Jin ^a,j   Kim, Woo Joo ^a,j  

^a Korea University College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Yonsei University Wonju   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Chungbuk National University College of Medicine   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

^h Pusan National University School of Medicine   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Transgovernmental Enterprise for Pandemic Influenza   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; BODY MASS; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SURVEILLANCE; DRUG EFFICACY; EMERGENCY WARD; EPIDEMIC; FEMALE; FLU LIKE SYNDROME; HEART DISEASE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; REVIEW; SMOKING; SOUTH KOREA; ADOLESCENT; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84921985073     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00673-14     Document Type: Review

References (22)

1. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. 2000. The impact of influenza epidemics on hospitalizations. J Infect Dis 181:831-837. Http: //dx.doi.org/10.1086/315320.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186. Http://dx.doi.org /10.1001/jama.289.2.179.
3. Peltola VT, Murti KG, McCullers JA. 2005. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 192:249-257. Http://dx.doi.org/10.1086/430954.
4. Zhou H, Haber M, Ray S, Farley MM, Panozzo CA, Klugman KP. 2012. Invasive pneumococcal pneumonia and respiratory virus co-infections. Emerg Infect Dis 18:294-297. Http://dx.doi.org/10.3201/eid1802.102025.
5. Nicholson KG. 1998. Human influenza, p 219-264. In Nicholson KG, Webster RG, Hay AJ (ed), Textbook of influenza. Blackwell Science Ltd, London, United Kingdom.
6. Song JY, Nahm MH, Cheong HJ, Kim WJ. 2014. Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia. PLoS One 9:e93477. Http://dx.doi.org/10.1371/journal.pone.0093477.
7. Ballinger MN, Standiford TJ. 2010. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res 30:643-652. Http://dx.doi.org/10.1089/jir.2010.0049.
8. Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, Jo YM, Seo YB, Kim WJ. 2007. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 55:273-281. Http://dx.doi.org/10.1016/j.jinf.2007.04.354.
9. Kim ES, Shin JK, Oh HK. 2014. Elderly immunization program against invasive pneumococcal disease in Korea 2013. Public Health Wkly Rep KCDC 7:182-186.
10. Song JY, Cheong HJ, Choi SH, Baek JH, Han SB, Wie SH, So BH, Kim HY, Kim YK, Choi WS, Moon SW, Lee J, Kang GH, Jeong HW, Park JS, Kim WJ. 2013. Hospital-based influenza surveillance in Korea: hospital- based influenza morbidity and mortality study group. J Med Virol 85:910-917. Http://dx.doi.org/10.1002/jmv.23548.
11. Bodí M, Rodríguez A, Solé-Violán J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J. 2005. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 41:1709-1716. Http://dx.doi.org/10.1086/498119.
12. American Thoracic Society Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416. Http://dx.doi.org/10.1164/rccm.200405-644ST.
13. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. 2012. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 206: 56-62. Http://dx.doi.org/10.1093/infdis/jis309.
14. Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A, Spanish Influenza Surveillance System. 2014. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative casecontrol studies using surveillance data, Spain, 2003-2011. Vaccine 32: 4404-4411. Http://dx.doi.org/10.1016/j.vaccine.2014.06.063.
15. Choi WS, Noh JY, Seo YB, Baek JH, Lee J, Song JY, Park DW, Lee JS, Cheong HJ, Kim WJ. 2013. Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory- confirmed influenza virus infection in the Korean adult population. Clin Vaccine Immunol 20:877-881. Http://dx.doi.org/10.1128 /CVI.00009-13.
16. Choi WS, Noh JY, Baek JH, Seo YB, Lee J, Song JY, Park DW, Lee JS, Cheong HJ, Kim WJ. Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations. PLoS One, in press.
17. Seo YB, Choi WS, Baek JH, Lee J, Song JY, Lee JS, Cheong HJ, Kim WJ. 2014. Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012. Hum Vaccin Immunother 10:423-427. Http://dx.doi.org/10.4161/hv.26858.
18. Sanford M. 2012. Pneumococcal polysaccharide conjugate vaccine (13- valent, adsorbed): in older adults. Drugs 72:1243-1255. Http://dx.doi.org /10.2165/11209330-000000000-00000.
19. Huss A, Scott P, Stuck AE, Trotter C, Egger M. 2009. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 180:48-58. Http://dx.doi.org/10.1503/cmaj.080734.
20. Christenson B, Hedlund J, Lundbergh P, Ortqvist A. 2004. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 23:363-368. Http://dx.doi.org/10.1183/09031936.04.00063504.
21. Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, González-Candelas F, Galán JC, Tamames S, Castro A, Baricot M, Garín O, Pumarola T. 2013. Effectiveness of vaccination with 23- valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. Hum Vaccin Immunother 9:865-873. Http://dx.doi.org/10.4161/hv.23090.
22. Nichol KL. 1999. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 17(Suppl 1):S91-S93. Http://dx.doi.org/10.1016 /S0264-410X(99)00114-0.